Pfizer and Moderna stocks drop after RFK Jr.'s nomination for Health Secretary: impact on the Pharma Industry
Shares of leading vaccine producers, such as Pfizer and Moderna, experienced notable drops after Robert F. Kennedy Jr. was announced as President-elect Donald Trumps nominee for Secretary of Health and Human Services.
Some of the most prominent companies in the industry are GlaxoSmithKline plc, Pfizer Inc., Sanofi Pasteur, Merck & Co., ...
TORONTO and PHILADELPHIA, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd (NASDAQ: MDCX TSXV: MDCX) (the “Company”) is pleased to announce the appointment of Faisal Mehmud, MD as Chief Medical ...
For the past three years, biotechs and pharmas have renamed, rebranded and more in a bid to refresh their corporate appeal. ...
Robert F. Kennedy Jr.'s chance to head the Department of Health and Human Services vexes Jake Tapper: "I hope you like ...
GSK is suing Pfizer, claiming Pfizer’s RSV vaccine, Abrysvo, infringes patents for GSK’s Arexvy. Both vaccines target older adults and compete in a market projected to exceed $10 billion by 2030.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback